case_images: PMC5398655_01
case_images: T2 of MRI (myoma [ ] endometrial thickening []). MRI indicates magnetic resonance imaging.
case_images: 10.1177_1179066017695239-fig1.jpg
case_images: PMC5398655_01_10.1177_1179066017695239-fig1.jpg
case_images: fig1-1179066017695239
case_images: A pelvic magnetic resonance imaging (MRI) showed the same image as endometrial thickening and uterine myomas (Figure 1).
case_images: Intraoperative finding (no tumor was found in the right ovary).
case_images: 10.1177_1179066017695239-fig2.jpg
case_images: PMC5398655_01_10.1177_1179066017695239-fig2.jpg
case_images: fig2-1179066017695239
case_images: Bilateral ovarian surface was smooth without macroscopic aspect of malignancy (Figures 2 and 3).
case_images: Intraoperative finding (no tumor was found in the left ovary).
case_images: 10.1177_1179066017695239-fig3.jpg
case_images: PMC5398655_01_10.1177_1179066017695239-fig3.jpg
case_images: fig3-1179066017695239
case_images: Bilateral ovarian surface was smooth without macroscopic aspect of malignancy (Figures 2 and 3).
case_images: Macroscopic finding (ovaries did not atrophy).
case_images: 10.1177_1179066017695239-fig4.jpg
case_images: PMC5398655_01_10.1177_1179066017695239-fig4.jpg
case_images: fig4-1179066017695239
case_images: The uterus and bilateral adnexa weighed 100 g (Figure 4).
case_images: The cut surface of the tumor (omicron) (the tumor of 12 mm in diameter) (hematoxylin-eosin, original magnification x1).
case_images: 10.1177_1179066017695239-fig5.jpg
case_images: PMC5398655_01_10.1177_1179066017695239-fig5.jpg
case_images: fig5-1179066017695239
case_images: The section of the left ovary revealed a yellow, solid tumor with a diameter of 12 mm (Figure 5).
case_images: The tumor (hematoxylin-eosin, original magnification x4).
case_images: 10.1177_1179066017695239-fig6.jpg
case_images: PMC5398655_01_10.1177_1179066017695239-fig6.jpg
case_images: fig6-1179066017695239
case_images: The cluster of Leydig cells with eosinophilic cytoplasm was identified between the cord of Sertoli cells (Figure 6 and 7).
case_images: Sertoli cell ( ), Leydig cell () (hematoxylin-eosin, original magnification x10)
case_images: 10.1177_1179066017695239-fig7.jpg
case_images: PMC5398655_01_10.1177_1179066017695239-fig7.jpg
case_images: fig7-1179066017695239
case_images: The cluster of Leydig cells with eosinophilic cytoplasm was identified between the cord of Sertoli cells (Figure 6 and 7).
case_images: Immunohistochemical analysis for the Sertoli-Leydig cell tumor (positive stain of alpha-inhibin in Sertoli cell and Leydig cell; original magnification x20).
case_images: 10.1177_1179066017695239-fig8.jpg
case_images: PMC5398655_01_10.1177_1179066017695239-fig8.jpg
case_images: fig8-1179066017695239
case_images: Immunohistochemical studies showed that the Sertoli cells and the Leydig cells were positive for alpha-inhibin (Figure 8).
case_images: Negative control in immunohistochemical hematoxylin-eosin (original magnification x20).
case_images: 10.1177_1179066017695239-fig9.jpg
case_images: PMC5398655_01_10.1177_1179066017695239-fig9.jpg
case_images: fig9-1179066017695239
case_images: The source and dilution of antibody of alpha-inhibin used for immunohistochemistry were Dako, Santa Clara, CA, United States (Monoclonal Mouse Anti-Human Inhibin alpha Cone R1, x20; Figure 9).